Headquarters: 651 Campus Drive
St. Paul, MN 55112
Cardiovascular Systems, Inc. (CSI) is a medical device company focused on developing and commercializing minimally invasive treatment solutions for vascular disease. The Company's primary products, the Diamondback 360 PAD System (Diamondback 360) and the Diamondback Predator 360 PAD System (Predator 360), are catheter-based platforms capable of treating a range of plaque types in leg arteries both above and below the knee and address many of the limitations associated with existing treatment alternatives. Diamondback 360 and the Predator 360 collectively are referred to as (Diamondback Systems). As of June 30, 2010, the Diamondback Systems have been utilized in an estimated 29,000 procedures. In addition to the Diamondback Systems, CSI is expanding its product portfolio through internal product development and establishment of business relationships. It offers multiple accessory products designed to complement the use of the Diamondback Systems.